The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption

Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice

(2010) H. Yasui et al.   CANCER RESEARCH

In vivo detection of inducible nitric oxide synthase in rodent gliomas

(2009) Rheal A. Towner et al.   FREE RADICAL BIOLOGY AND MEDICINE

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

(2009) Randy L. Jensen   JOURNAL OF NEURO-ONCOLOGY

The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects

(2009) D. L. Schwartz et al.   MOLECULAR CANCER THERAPEUTICS

Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI

(2009) S. Matsumoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress

(2009) Mark W. Dewhirst   RADIATION RESEARCH

Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography

(2008) Taketoshi Asanuma et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole

(2008) Rumi Murata et al.   RADIOTHERAPY AND ONCOLOGY